1-3 of 3
Robert J. Oldham
Close
Sort by
Journal Articles

PI3Kδ Inhibition Elicits Anti-Leukemic Effects through Bim-Dependent Apoptosis

Matthew J Carter, PhD, Kerry L Cox, Stuart J Blakemore, Anna H Turaj, MSc, Robert J Oldham, Lekh N. Dahal, PhD, Stacey Tannheimer, Francesco Forconi, MD DM, PhD FRCPath, Graham Packham, PhD, Mark S Cragg, PhD
Journal: Blood
Blood (2016) 128 (22): 3241.
https://doi.org/10.1182/blood.V128.22.3241.3241
Published: 2016
Journal Articles

Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies

Thomas R. W. Tipton, Ali Roghanian, Robert J. Oldham, Matthew J. Carter, Kerry L. Cox, C. Ian Mockridge, Ruth R. French, Lekh N. Dahal, Patrick J. Duriez, Philip G. Hargreaves, Mark S. Cragg, Stephen A. Beers
Journal: Blood
Blood (2015) 125 (12): 1901–1909.
https://doi.org/10.1182/blood-2014-07-588376
Published: 2015
Includes: Supplemental data
Journal Articles

Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412

Khiyam Hussain, Chantal E. Hargreaves, Ali Roghanian, Robert J. Oldham, H. T. Claude Chan, C. Ian Mockridge, Ferdousi Chowdhury, Bjorn Frendéus, Kirsty S. Harper, Jonathan C. Strefford, Mark S. Cragg, Martin J. Glennie, Anthony P. Williams, Ruth R. French
Journal: Blood
Blood (2015) 125 (1): 102–110.
https://doi.org/10.1182/blood-2014-08-593061
Published: 2015
Includes: Supplemental data